InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.66
(
0.08%
)
Bitcoin
62,712.10
(
3.18%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mcd2inga

Send PM Follow Ignore
Followers 0
Posts 191
Boards Moderated 0
Alias Born 07/16/2005

mcd2inga

Re: mysscat post# 9358

Sunday, 09/02/2007 9:54:59 PM

Sunday, September 02, 2007 9:54:59 PM

Post# of 30387
mysscat,
I agree. We should make sure they are up on the latest developments. You would think that they would have realized by now that they need to keep up with this board. LOL

From Half Full's info on our research team, it made me hope that any results presented at ISOBM would all show effectiveness with a variety of cancer types.
Petra Stieber - experience with Breast Cancer
Stephen Frost - experience with Lung Cancer
Barry Dowell - experience with Colorectal Cancer

It would be great to show effectiveness across many cancer types. This would reinforce the company's previous results.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up